甲福明作为治疗轻度至中度性性结肠炎的潜在辅助药物:一项双盲,随机,安慰剂控制的试点研究
Mehdi Molavi1, Bahareh Amin2, Mohammad Sahebkar3,4
1Department of Internal Medicine, Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Internal and emergency medicine
|December 10, 2025
概括
辅助的甲福明显著降低了性结肠炎 (UC) 患者的疾病活性. 这项试点研究表明,甲双作为一种潜在的治疗方法来管理UC恶化,需要进一步调查.
科学领域:
- 胃肠病学和肝病学
- 临床药理学 临床药理学
- 炎症性肠道疾病研究研究
背景情况:
- 尽管治疗方面取得了进展,但治疗复发性性结肠炎 (UC) 存在持续的临床挑战.
- 梅特福林是一种已知抗糖尿病药物,具有抗炎性质,这表明它在UC管理中具有潜在的实用性.
- 正在探索辅助疗法,以改善轻度至中度UC患有急性恶化症状的患者的治疗结果.
研究的目的:
- 评估辅助甲福明在急性恶化期间减轻轻度至中度性结肠炎患者疾病活性方面的疗效.
- 与安慰剂相比,评估甲胺对UC疾病活动指数 (UCDAI) 的影响.
主要方法:
- 一个双盲,随机,安慰剂控制的试验试验,涉及112名患有轻度至中度UC的患者.
- 参与者每天两次服用1000毫克甲福尔或安慰剂,除了他们的常规治疗,两个月.
- 测量的主要结果是治疗后UCDAI得分的变化.
主要成果:
- 与安慰剂组相比,甲福林组的UCDAI得分明显较低 (P=0.004).
- 顺序逻辑回归表明,在甲福林组中,UCDAI得分较高的概率降低了54% (OR 0.46;P=0.044).
- 辅助的甲福明与疾病活动的显著减少有关.
结论:
- 辅助甲福明在治疗性结肠炎的急性恶化中发挥了潜在的治疗作用.
- 这些发现支持使用甲双来降低UC患者的疾病活性.
- 需要进行更大规模的临床试验来证实这些结果,并阐明甲胺在UC中的抗炎机制.
更多相关视频
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
3.3K
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.7K
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
413
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
413
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
554
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
554
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
447
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
447
01:21Drugs for Treatment of Constipation-Predominant IBS
664
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
664
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
402
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
402